Trending...
- IRF Builders Forum Brings Global Leaders to Washington, D.C. to Advance Religious Freedom Through Cooperative Engagement
- Suzanne Harp named Managing Director in Texas, USA
- Penn Mutual Earns 2025 Great Place To Work Certification™
~ Harrisburg, PA - Governor Josh Shapiro is urging health insurers in Pennsylvania to make contraception more accessible and affordable without unnecessary hurdles. This call to action comes after the recent launch of the first ever FDA approved over-the-counter (OTC) daily birth control pill, Opill.
Governor Shapiro has always been a strong advocate for women's access to reproductive healthcare and is now calling on other insurers to follow the lead of major companies CVS Health Plans and Geisinger Health Plans. These two insurers have announced that they will cover OTC contraception with or without a prescription at no cost.
"I am glad to see that CVS Health Plans are joining Geisinger Health Plans to cover Opill without a prescription - and more insurers should follow suit," said Governor Shapiro. "I've always fought to protect and defend access to reproductive healthcare, and my Administration will continue to hold insurers accountable and ensure that women have the personal freedom to make choices over their own bodies."
More on The PennZone
In an effort to encourage other insurers in Pennsylvania to adopt this best practice, Governor Shapiro's Administration has issued guidance for health insurers to cover OTC birth control with or without a prescription. The Pennsylvania Insurance Department (PID) is also asking insurers who choose not to cover OTC contraception options to provide additional information on why they are not complying with federal law and regulations.
"We are glad to see insurers continue to take steps towards a best practice that ensures Pennsylvanians are empowered with choices in their reproductive healthcare," said Pennsylvania Insurance Commissioner Michael Humphreys. "The Shapiro Administration is committed to supporting women's freedom to make their own healthcare decisions and the right to access the full scope of reproductive health care."
Not only does insurance coverage of OTC contraception provide easier access for women, but it can also save them nearly $250 a year. The FDA recently approved Opill (norgestrel) for nonprescription use, making it available for purchase at drug stores, convenience stores, grocery stores, and online without a prescription. This means that individuals will no longer need to see a healthcare provider before obtaining this contraceptive medication.
More on The PennZone
Opill has been classified as a progestin-only pill, which is considered a safer option for individuals with certain medical conditions such as high blood pressure, diabetes, and cardiovascular disease. According to the FDA, when taken correctly, Opill is expected to be the most effective non-prescription contraception method available. This could potentially help reduce the number of unintended pregnancies in Pennsylvania, which currently accounts for almost half of the over six million pregnancies annually in the U.S.
Pennsylvanians who have any insurance related questions or issues can file a complaint with PID's Consumer Services Bureau or by calling 1-877-881-6388.
Governor Shapiro's call for insurers to cover OTC contraception comes at a crucial time when access to reproductive healthcare is being threatened. With this new option available for women in Pennsylvania, it is hoped that other insurers will follow suit and make contraception more accessible and affordable for all.
Governor Shapiro has always been a strong advocate for women's access to reproductive healthcare and is now calling on other insurers to follow the lead of major companies CVS Health Plans and Geisinger Health Plans. These two insurers have announced that they will cover OTC contraception with or without a prescription at no cost.
"I am glad to see that CVS Health Plans are joining Geisinger Health Plans to cover Opill without a prescription - and more insurers should follow suit," said Governor Shapiro. "I've always fought to protect and defend access to reproductive healthcare, and my Administration will continue to hold insurers accountable and ensure that women have the personal freedom to make choices over their own bodies."
More on The PennZone
- Lore Link is Here to Help Organize Your Game
- Chappaqua's Annual Townwide Summer Sale – Unbeatable Savings at Your Favorite Local Boutiques!
- Skyline Partners with ZenSpace to Offer Private Meeting Pods for Trade Show Exhibitors
- VIP Vacations Honored as One of the Top 25 Group Accounts for Classic Vacations for 2024
- DICK'S Sporting Goods Announces DICK'S Deal Days, a Four-Day Summer Savings Event
In an effort to encourage other insurers in Pennsylvania to adopt this best practice, Governor Shapiro's Administration has issued guidance for health insurers to cover OTC birth control with or without a prescription. The Pennsylvania Insurance Department (PID) is also asking insurers who choose not to cover OTC contraception options to provide additional information on why they are not complying with federal law and regulations.
"We are glad to see insurers continue to take steps towards a best practice that ensures Pennsylvanians are empowered with choices in their reproductive healthcare," said Pennsylvania Insurance Commissioner Michael Humphreys. "The Shapiro Administration is committed to supporting women's freedom to make their own healthcare decisions and the right to access the full scope of reproductive health care."
Not only does insurance coverage of OTC contraception provide easier access for women, but it can also save them nearly $250 a year. The FDA recently approved Opill (norgestrel) for nonprescription use, making it available for purchase at drug stores, convenience stores, grocery stores, and online without a prescription. This means that individuals will no longer need to see a healthcare provider before obtaining this contraceptive medication.
More on The PennZone
- AI Innovation Dual-Strategy Business Model Focused on Real Estate Development for Strategic Expansion: OFA Group, (N A S D A Q: OFAL)
- Construcción del Corredor Norte–Sur (NSC) de Singapur
- New Report: Slip and Fall Accidents Rank as the Leading Cause of Construction Site Fatalities
- Get Your Cowboy Boots On! Causeway Country BBQ Music Festival Kicks Off September 12–14 in Ft. Pierce
- Retired Hobbyist Launches Bold Weekly Album Project Using AI Songwriting Tools
Opill has been classified as a progestin-only pill, which is considered a safer option for individuals with certain medical conditions such as high blood pressure, diabetes, and cardiovascular disease. According to the FDA, when taken correctly, Opill is expected to be the most effective non-prescription contraception method available. This could potentially help reduce the number of unintended pregnancies in Pennsylvania, which currently accounts for almost half of the over six million pregnancies annually in the U.S.
Pennsylvanians who have any insurance related questions or issues can file a complaint with PID's Consumer Services Bureau or by calling 1-877-881-6388.
Governor Shapiro's call for insurers to cover OTC contraception comes at a crucial time when access to reproductive healthcare is being threatened. With this new option available for women in Pennsylvania, it is hoped that other insurers will follow suit and make contraception more accessible and affordable for all.
0 Comments
Latest on The PennZone
- INVESTIGATION ALERT: Berger Montague PC Investigates Aflac, Inc.'s Board Of Directors For Breach of Fiduciary Duties (NYSE: AFL)
- AI-Based Neurotoxin Countermeasure Initiative Launched to Address Emerging National Security Needs: Renovaro, Inc. (N A S D A Q: RENB)
- The Naturist World Just Shifted — NaturismRE Ignites a Global Resurgence
- $796,000 in Q2 Revenue Marks Highest Earnings to Date on 3 Trailing Quarters of Profitability in Multi-Billion Homebuilding Sector: Stock Symbol: IVDN
- Cybersecurity is THE Hot Market Sector; Revenues, Earnings & Profit matter; Only 33 Million Shares + a Huge Short Position Equal an Undervalued Stock
- Despite Global Calls for a Ban, US Child Psychiatry Pushes Electroshock for Kids
- BeyondTrucks CEO Wins Gold Stevie® Award for Best Entrepreneur in Transportation
- Franco Polished Plaster Celebrates 35 Years of Bringing Walls to Life in the UK
- Spartan & Guardians Partner with Guitar Legend Buckethead to Support Global Child Rescue Efforts
- C8C.AI Launches Audio Compliance Engine to Streamline Ethical AI Audio Data at Scale
- Preliminary.online Introduces Short-Term Job-Readiness Courses with Employer-Verified Certifications
- Psychologist-Turned-Hermeticist Releases Modern Guide to the Seven Hermetic Principles
- Winners Announced for Asia Pacific Business Awards 2024-2025
- Medwave Recognized Among Top 10 Medical Billing Companies in USA by MedicoLeads
- Hamvay-Lang and Lampone.hu Join Forces with AIMarketingugynokseg.hu to Elevate Hungarian Lifestyle Brands on the Global Stage
- Why HVAC Cleaning Is So Important In Philadelphia
- Google AI Quietly Corrects the Record on Republic of Aquitaine's Legal Sovereignty
- NYC Leadership Strategist Stacie Selise Launches Groundbreaking 4S Framework Series to Redefine Executive Excellence
- Make Innovation Matter: Support H.R.1's R&D Expensing Relief for American Small Businesses
- Agreement to Supply US-Based Defense Provider with Thin-Film Solar Tech for Orbital Application; Ascent Solar Technologies, Inc. (N A S D A Q: ASTI)